Bliss GVS Pharma Limited has informed the Exchange regarding Grant of 268000 Options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma's Nomination and Remuneration Committee has granted 2,68,000 stock options to eligible employees under the company's Employee Stock Option Plan 2019. Each option is convertible into one equity share of Re. 1 face value, with an exercise price of Rs. 43 per share. This exercise price reflects a 72.28% discount to the NSE closing price of Rs. 155.08 on July 28, 2025, and matches the exercise price of earlier options already granted. The options will vest in four equal tranches of 25% each over four years (after 12, 24, 36, and 48 months), with a 6-month exercise window after each vesting and a 6-month lock-in on shares issued. The grant was approved on July 29, 2025.
This is a routine employee incentive grant and not dilutive in the immediate term since no options have vested or been exercised yet. Over 3-4 years, up to 2.68 lakh new shares could be issued (small relative to typical share base), creating mild future dilution. The deep 72% discount to market suggests retention-focused grants at pre-set prices, with limited direct impact on current shareholders.